跳至主要内容
临床试验/CTRI/2009/091/000356
CTRI/2009/091/000356已完成4 期

The effect of a topical application of Diltiazem or a combination of Diltiazem and Lidocaine in various anal conditions.

Troikaa Pharmaceuticals Limited0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adult patients of either sex aged 18 - 60 years.
  • 2.Patients diagnosed with chronic anal fissure, hemorrhoids and patients undergoing elective anal surgery.

排除标准

  • 1.Patients having anal fistulas or anal fissure of various causes such as Crohn disease, anal suppuration, abscesses,
  • 2.Patients with associated acute haemorrhoidal attacks
  • 3.Patients having anal or perianal malignancy
  • 4.Patients who have been surgically treated previously
  • 5.Patients on oral CCBs./ nitrates/ vasodilators
  • 6.Known hypersensitivity to diltiazem
  • 7.Pregnant women /lactating mother
  • 8.Patients with the history of HIV infection

研究者

相似试验